Global Trac Solutions (OTCPink: PSYC) has reported significant growth in its Psychedelic Spotlight platform, achieving over 40% increases in users and sessions from January to February. This expansion allows the company to explore revenue opportunities through advertising and partnerships, marking its first potential steady revenue stream since entering the medicinal psychedelics market. CEO David Flores emphasized the platform's established reputation as a trusted source in the industry, signaling a strategic shift towards monetization in the coming months, aiming to reflect revenue in financials soon.
Global Trac Solutions (OTCPink: PSYC) announces its $10,000 sponsorship of the Fireside Project, launching a 24/7 psychedelic peer support hotline on April 14, 2021. This initiative aims to provide free, confidential support to individuals experiencing psychedelic effects. PSYC emphasizes its commitment to the emerging psychedelic sector, especially as local governments explore decriminalization. CEO David Flores highlights the importance of community and safe substance use for supporting the psychedelic movement, aiming to inspire broader engagement in this area.
Global Trac Solutions, Inc. (OTCPink: PSYC) announced the release of its September Microdose Monthly newsletter featuring an exclusive interview with Dr. Albert Garcia-Romeu of Johns Hopkins. This edition highlights ongoing clinical trials focusing on the efficacy of psilocybin for tobacco dependence and mental health conditions. CEO David Flores emphasized the importance of sharing such research to keep audiences informed about psychedelic medicine advancements. As regulatory attitudes shift, PSYC aims to position itself at the forefront of this emerging industry.
Global Trac Solutions, Inc. (OTCPink: PSYC) has established an affiliate partnership with BodyChek Wellness to promote functional mushroom products, emphasizing mental health and wellness. The partnership will focus initially on BodyChek's 'Enhance Mushroom +' products designed for focus and energy. CEO David Flores highlighted the importance of leveraging their platform within the psychedelic community, noting the growing popularity of functional mushrooms as cognitive supplements. BodyChek's founder, Riley Cote, expressed excitement about the collaboration aimed at advancing awareness of mushrooms' healing properties.